Interleukin-1 (IL-1) is a key player in inflammation and the immune response. To better understand the complex interactions of IL-1 and its receptors in inflammation, we need to investigate how type I and type II IL-1 receptors (IL-1RI and IL-1RII) are regulated by cytokines and other mediators. Using semiquantitative reverse transcriptase PCR and Northern analysis, we examined the regulation of IL-1RI and IL-1RII mRNA levels in bovine polymorphonuclear leukocytes (PMNs) (i.e., neutrophils) and peripheral blood mononuclear cells (PBMCs) in vitro. IL-1RI mRNA levels were up-regulated in PBMCs by recombinant bovine IL-1␤ (rBoIL-1␤), recombinant bovine granulocyte-macrophage colony-stimulating factor (rBoGM-CSF), rBoIL-4, recombinant bovine gamma interferon (rBoIFN-␥), and dexamethasone. IL-1RI mRNA was increased in bovine PMNs exposed to rBoGM-CSF, rBoIL-4, and dexamethasone but was down-regulated by rBoIL-1␤ and rBoIFN-␥. IL-1RII mRNA was increased in bovine PBMCs and PMNs after exposure to rBoIL-1␤, rBoGM-CSF, rBoIL-4, and dexamethasone. In contrast, rBoIFN-␥ down-regulated the expression of bovine IL-1RII mRNA in PBMCs. These findings suggest that the expression of bovine IL-1RI and IL-1RII mRNAs is regulated differently by certain soluble stimuli (e.g., IFN-␥) in PMNs and PBMCs.
Two distinct types of interleukin-1 (IL-1) receptors, type I (IL-1RI) and type II (IL-1RII), have been reported (17, 19, 24, 28, 33) . IL-1RI is larger and contains a long cytoplasmic tail that is involved in signal transduction. As a result, it is the functional IL-1 receptor that is responsible for mediating the biological effects of IL-1 (7, 9, 21, 29) . In contrast, IL-1RII is smaller, lacks the long cytoplasmic region, and hence is not involved in signal transduction. Instead, IL-1RII acts as a decoy receptor for IL-1 (8, 21, 29) . The relative levels of IL-1RI and IL-1RII are important in determining the biological response to IL-1 (8, 11) .
Regulation of IL-1RI expression seems to be cell specific (10) . IL-1␤ increased IL-1RI expression in human fibroblasts (14) but suppressed expression in human intestinal epithelial cells (18) and murine TH 2 lymphocytes (24, 36) . IL-1RII expression was markedly up-regulated by IL-1 in murine bone marrow cells (12) and by IL-4 in human neutrophils (9) . In addition, glucocorticoids such as dexamethasone increased the expression of IL-1RII on various cell types, including human peripheral blood mononuclear cells (PBMCs) (1, 30) , neutrophils (26, 27, 30) , and B cells (32) .
There is limited information regarding IL-1 receptors in species other than humans and rodents. We have cloned and sequenced the bovine IL-1RI (22) and IL-1RII (37) . IL-1RI and IL-1RII mRNAs are widely distributed in bovine cells, having been detected in bovine leukocytes, fibroblasts, spleen cells, thymocytes, liver cells, endometrium, and mammary epithelial cells (37) . There appears to be tissue-specific regulation of IL-1R in bovines, since there are at least two transcripts (1.5 and 2.0 kb) for the bovine IL-1RII, which vary in relative abundance in different cell types (37) . In the present study, we examined the in vitro regulation of IL-1RI and IL-1RII mRNA levels in bovine PBMCs and polymorphonuclear leukocytes (PMNs) in response to various relevant stimuli (e.g., cytokines and dexamethasone). This study provides new insights into the regulation of IL-1-mediated inflammation in bovines and describes a new model for investigating the comparative biology of IL-1 receptors.
MATERIALS AND METHODS
Reagents. All chemicals and reagents were purchased from Sigma Chemical Co. (St. Louis, Mo.) unless otherwise noted. Recombinant bovine IL-1␤ (rBoIL-1␤), rBoIL-2, and recombinant bovine granulocyte-macrophage colony-stimulating factor (rBoGM-CSF) were generous gifts from Dale Shuster (American Cyanamid, Princeton, N.J.). rBoIL-4 was provided by Mark Estes (University of Missouri, Columbia). Recombinant bovine gamma interferon (rBoIFN-␥) was obtained from Lorne Babiuk (VIDO, Saskatoon, Canada), and recombinant human tumor necrosis factor alpha (rHuTNF␣) was generously provided by A. Creasey (Cetus, Emeryville, Calif.). Fetal bovine serum (FBS) was purchased from Intergen (Purchase, N.Y.). Guanidinium isothiocyanate (GITC) and CsCl were purchased from Fisher Scientific (Pittsburgh, Pa.). RPMI-1640 was obtained from GIBCO BRL (Gaithersburg, Md.).
Cell purification. Peripheral blood was obtained by venipuncture from the jugular veins of healthy Holstein cattle, using sodium citrate (0.38% final volume) as the anticoagulant. The blood was centrifuged (400 ϫ g for 20 min) to collect the buffy coat cells. These were subsequently centrifuged (20 min at 400 ϫ g at room temperature) through a Ficoll-Hypaque gradient (1.080), and the PBMCs were aspirated from the gradient interface as described previously (31) . The packed erythrocyte layers were then collected and subjected to rapid hypotonic lysis, and the resulting leukocyte suspension was centrifuged through a 65% Percoll gradient to isolate the PMNs, as described previously (23) . Purified PBMCs and PMNs were resuspended at a final concentration of 5 ϫ 10 6 cells/ml in RPMI containing 5% FBS. These cell suspensions were more than 95% PBMCs and PMNs, respectively, as determined by differential staining with Diff-Quick (American Scientific Products, McGaw Park, Ill.), and greater than 99% viable, as determined by trypan blue exclusion. To assess regulation of IL-1RI and IL-1RII mRNAs, the cell suspensions were incubated with dexamethasone (10 Ϫ7 M), rBoIL-1␤ (10 ng/ml), rBoGM-CSF (100 ng/ml), rBoIL-4 (100 ng/ml), rBoIFN-␥ (100 ng/ml), or medium alone (negative control) at 39°C for 6 h. Preliminary experiments compared results after 4, 6, or 8 h of incubation and found that 6 h gave maximal signals.
Semiquantitative RT-PCR. Total RNA was extracted from bovine PMNs or PBMCs and then purified on CsCl gradients by standard methods (16) . RNA concentrations were determined spectrophotometrically (A 260 /A 280 ). cDNA that was prepared from 0.3 g of total RNA by using reverse transcriptase (RT) was amplified at an annealing temperature of 64°C for 27 cycles for IL-1RI and IL-1RII and 25 cycles for glucose-3-phosphate dehydrogenase (G3PDH), essentially as described previously (15, 25) . These conditions were confirmed as being in the linear range for each cytokine cDNA product (data not shown). The amplimer sequences for IL-1RI were as follows: sense primer, 5Ј-CACTCTGC TGGACTCTAAGGAG-3Ј; antisense primer, 5Ј-CCTAAATCTGTCTATAGA TGGTG-3Ј. For IL-1RII the sequences were as follows: sense primer, 5Ј-GGT CCAGGCTGGCAATCCCATG-3Ј; antisense primer, 5Ј-CTTCTTTGACCGT GGTACGAAGC-3Ј. For G3PDH the sequences were as follows: sense primer, 5Ј-CCTTCATTGACCTTCACTACATGGTCTA-3Ј; antisense primer, 5Ј-GCT GTAGCCAAATTCATTGTCGTTACCA-3Ј. Amplification of G3PDH was employed as an internal control. Reactions without cDNA were included as negative controls. The cDNA products were then electrophoresed through 1% agarose gels, and the signals were visualized after being stained with ethidium bromide. The stained gels were then photographed and scanned with a DeskScan II scanner (Hewlett-Packard, San Diego, Calif.), and the scanned image was reproduced with the CorelDraw PhotoPaint software package.
Northern blot analysis. Total RNA (10 to 20 g per lane) was fractionated by electrophoresis through 1% agarose gels containing 6.7% formaldehyde, as described previously (14) , and the RNA was transferred to Hybond-N ϩ membranes (Amersham, Arlington Heights, Ill.). The membranes were prehybridized in 50% formamide-5ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate) at 42°C for 2 h and then hybridized at 42°C overnight with 32 P-labeled cDNA probes specific for bovine IL-1RII (1.8-kb full-length clone) or IL-1RI (21) . The cDNA probes were labeled with 32 P by nick translation (GIBCO BRL). The blots were washed three times, with the final wash in 0.2ϫ SSC-0.1% sodium dodecyl sulfate at 62°C for 30 min, and then exposed to Kodak BioMax films with intensifying screens at Ϫ70°C. The signals were quantified by scanning densitometry with a Personal Densitometer SI (Molecular Dynamics Inc., Sunnyvale, Calif.). The autoradiograms were scanned with a DeskScan II (Hewlett-Packard Co.), using CorelDraw PhotoPaint computer software.
RESULTS
We first used semiquantitative RT-PCR to examine IL-1RI and IL-1RII mRNA levels in bovine PBMCs and PMNs incubated with various stimuli. As illustrated in Fig. 1A , PMNs incubated with rBoIL-1␤ exhibited decreased IL-1RI mRNA levels and increased IL-1RII mRNA levels, as determined by visual examination of the signals in ethidium bromide-stained 1% agarose gels. Incubation of PMNs with rBoGM-CSF (Fig.  1B) had little apparent effect on IL-1RI mRNA levels but appeared to increase IL-1RII mRNA levels. The effects of several cytokines, and the glucocorticoid dexamethasone, on PBMCs were also examined. As illustrated in Fig. 1A , incubation of PBMCs for 6 h with dexamethasone appeared to increase the signals for both IL-1RI and IL-1RII mRNAs. There was little change in IL-1RI and IL-1RII mRNA levels after incubation of PBMCs with lipopolysaccharide. Incubation of PBMCs with rBoIL-1␤ increased both IL-1RI and IL-1RII mRNA levels, with a greater effect on the signal for the latter. Incubation of bovine PBMCs with rHuTNF-␣, rBoIL-2, or rBoGM-CSF appeared to have little effect on IL-1RI and IL-1RII mRNA levels. Incubation of PBMCs with rBoIFN-␥ had little effect on IL-1RI mRNA levels but appeared to decrease IL-1RII mRNA levels.
We next attempted to confirm our RT-PCR data by performing Northern analysis of IL-1RI and IL-1RII mRNA levels in PBMCs and PMNs. IL-1RI mRNA levels were up-regulated approximately 5.2-fold (as determined by densitometric analysis) by incubation of PBMCs with dexamethasone, 4.0-fold by rBoIL-1␤, 3.5-fold by rBoGM-CSF, 4.5-fold by rBoIL-4, and 2.3-fold by rBoIFN-␥ ( Fig. 2A) . Although the effects of dexamethasone and rBoIL-1␤ were consistent with our RT-PCR results (as shown in Fig. 1A ), these stimuli differed in their relative effects on IL-1 receptors in PMNs. As illustrated in Fig. 2B , IL-1RI mRNA in PMNs was up-regulated approximately fourfold by dexamethasone but down-regulated twofold by rBoIFN-␥ and threefold by rBoIL-1␤. The inhibitory effect of rBoIL-1␤ on IL-1RI mRNA levels in PMNs (Fig. 2B) is consistent with the RT-PCR data presented in Fig.  1A . IL-1RI mRNA expression in PMNs was unaffected by a 6-h incubation with rBoGM-CSF or rBoIL-4 (Fig. 2B) . Neither IL-1RI mRNA nor IL-1RII mRNA levels in PMNs were affected by exposure to rBoIL-2, as determined by either semiquantitative RT-PCR (Fig. 1) or Northern analysis (data not shown).
As shown in Fig. 3A , IL-1RII mRNA in bovine PBMCs was increased approximately 72-fold following incubation with dexamethasone, sevenfold by rBoIL-1B, 4.2-fold by rBoIL-4, and 6.6-fold by rBoGM-CSF. These findings were generally consistent with the results obtained by RT-PCR. The apparent inhibitory effect of rBoIFN-␥ on IL-1RII mRNA in PBMCs noted with RT-PCR (Fig. 1B) 2) and PBMCs (lanes 3 to 6) were incubated at 39°C for 6 h with rBoIL-1␤ (10 ng/ml), dexamethasone (Dex) (10 Ϫ7 M), or lipopolysaccharide (LPS) (100 ng/ml) in RPMI-1640 with 5% FBS. (B) PMNs (lanes 1 and 2) and PBMCs (lanes 3 to 7) were incubated at 39°C for 6 h with rBoGM-CSF (100 ng/ml), rHuTNF␣ (100 ng/ml), rBoIFN-␥ (100 ng/ml), or rBoIL-2 (100 ng/ml) in RPMI-1640 with 5% FBS. The cells were lysed in 5.5 M GITC, and total RNA was extracted, reverse transcribed, and amplified (27 cycles) with IL-1RII-specific primers. G3PDH was amplified for 25 cycles and used as a control for each reaction mixture. Control lanes refer to cells incubated in medium alone (RPMI-1640 with 5% FBS). The results in panels A and B were confirmed with cells from three and two different donors, respectively.
FIG. 2.
Northern analysis of IL-1RI mRNA in bovine PBMCs and PMNs incubated with various stimuli. (A) PBMCs were incubated at 39°C for 6 h with dexamethasone (Dex) (10 Ϫ7 M), rBoIL-1␤ (IL-1) (10 ng/ml), rBoGM-CSF (GM) (100 ng/ml), rBoIL-4 (IL-4) (100 ng/ml), or rBoIFN-␥ (IFN) (100 ng/ml), and total RNA (20 g) was examined by Northern analysis. The blot was probed with 32 P-labeled IL-1RI cDNA, and the autoradiogram was exposed for 24 h. (B) PMNs were incubated at 39°C for 6 h with dexamethasone (10 Ϫ7 M), rBoIFN-␥ (100 ng/ml), rBoGM-CSF (100 ng/ml), rBoIL-4 (100 ng/ml), or rBoIL-1␤ (10 ng/ml), and total RNA (10 g) was examined by Northern analysis. The blots were probed with 32 P-labeled IL-1RI cDNA, and the autoradiograms were exposed for 1 to 3 days. The lower parts of both panels illustrate ethidium bromide staining of the 18S and 28S rRNA bands to confirm equal loading of the lanes. Control lanes (C) refer to cells incubated in medium alone (RPMI-1640 with 5% FBS). This figure illustrates one representative experiment of three separate experiments that were performed.
Northern analysis, since IL-1RII mRNA was not detected by Northern analysis of total RNA from either untreated or IFN-␥-stimulated PBMCs (Fig. 3A) . As shown in Fig. 3B , IL-1RII mRNA in PMNs was increased approximately 55-fold by dexamethasone, 27-fold by rBoIL-1, 9.3-fold by rBoGM-CSF, and 8.5-fold by rBoIL-4 as compared with that in untreated PMNs.
DISCUSSION
Our data suggest that IL-1RI and IL-1RII steady-state mRNA levels are regulated differently in bovine PMNs and PBMCs. IL-1RI mRNA levels were up-regulated in PBMCs but down-regulated in PMNs by incubation with the cognate ligand IL-1␤. Similar down-regulation of IL-1RI in response to IL-1␤ has been shown previously for human intestinal epithelial cells (18) and murine TH 2 lymphocytes (D10 cells) (24) . Although the mechanism was not investigated in the present study, perhaps the IL-1␤ destabilized IL-1RI mRNA. This possibility is consistent with the observation of Takii et al. (34) , who suggested that IL-1␤ activates an RNase which recognizes an AT-rich sequence located in the 3Ј untranslated region of murine IL-1RI (5). Alternatively, the contradictory effects of IL-1␤ on IL-1RI mRNA levels in PBMCs and PMNs might be explained by the involvement of distinct signal transduction pathways. For example, Takii et al. (34) suggested that IL-1RI mRNA was down-regulated in cells which do not synthesize prostaglandin E 2 in response to IL-1␤.
In contrast to the differential effects of IL-1␤ on IL-1RI mRNA, IL-1RII mRNA was uniformly up-regulated by rBoIL-1␤ in PBMCs and PMNs. The mechanism by which rBoIL-1␤ increases IL-1RII mRNA levels is not clear. One possibility might be that IL-1␤ directly activates IL-1RII gene transcription, as shown previously by Bristulf et al. (4) with Rinm5F cells. In addition, we cannot exclude the possibility that exposure of PBMCs and PMNs to IL-1␤ increased the half-life of IL-1RII mRNA. Another possibility is that IL-1␤-induced prostaglandin E 2 synthesis, and subsequent cyclic AMP (cAMP) accumulation, might also play a role in the up-regulation of IL-1RII mRNA levels (35) . Whatever the mechanism, our data suggest that exposure of bovine leukocytes to IL-1␤ would increase IL-1RII mRNA levels and subsequently dampen IL-1-mediated inflammation.
Bovine PBMCs and PMNs differed in their response to GM-CSF. A 6-h exposure to rBoGM-CSF increased IL-1RI mRNA levels in bovine PBMCs but had little or no effect on IL-1RI mRNA levels in PMNs. Whether this represents a temporal difference in response to rBoGM-CSF has not been examined. Conversely, incubation with rBoGM-CSF increased IL-1RII mRNA levels in both PBMCs and PMNs. These effects were more apparent by Northern analysis than RT-PCR, which might reflect the greater reliability and more quantitative nature of the former procedure. Our data are consistent with a previous report by Dubois et al. (12) regarding regulation of IL-1RII by GM-CSF in mouse bone marrow cells.
The relative effects of rBoIL-4 and rBoIFN-␥ on IL-1RI mRNA in bovine PBMCs and PMNs were complex. IL-4 is a TH 2 cytokine that is generally thought to be anti-inflammatory (20) , whereas IFN-␥ often potentiates the inflammatory response (3). IL-4 blocked the ability of IL-1␤ to prolong the survival of human PMNs in vitro (9) , probably via its ability to up-regulate the decoy receptor IL-1RII. IL-1RI mRNA levels in PBMCs were increased by exposure to rBoIL-4 or rBoIFN-␥. In contrast, IL-1RI mRNA levels in PMNs were decreased by IFN-␥ and unaffected by IL-4. These observations differ from a previous report that rHuIL-4 up-regulated IL-1RI mRNA in human neutrophils (8) . The ability of rBoIFN-␥ to increase IL-1RI mRNA in PBMCs in the present study is similar to a previous report that IFN-␥ increased the numbers of IL-1RI on murine keratinocytes (30) . rBoIL-4 upregulated IL-1RII mRNA levels in bovine PBMCs and PMNs. In contrast, rBoIFN-␥ reduced IL-1RII mRNA levels in PBMCs and PMNs, as assessed by semiquantitative RT-PCR (Fig.  1) . Because of the limited amounts of IL-1RII mRNA present in untreated and IFN-␥-treated PBMCs and PMNs, we were unable to confirm these observations by Northern analysis. Use of poly(A) ϩ mRNA might confirm the inhibitory effect of IFN-␥ on IL-1RII mRNA levels, but we did not explore this possibility.
Dexamethasone is a potent anti-inflammatory agent. We found that incubation of bovine PBMCs and PMNs with dexamethasone up-regulated both IL-1RI and IL-1RII mRNA levels. These results agree with our previous in vivo studies with cattle (38) and studies of the effects of dexamethasone on human neutrophils (9, 21, 26) and monocytes (12, 30) and in mouse brains (2) . Our data, and those from the prior studies, provide evidence that the anti-inflammatory effects of dexamethasone include modulation of IL-1 receptors. There are several possible mechanisms for the effects of dexamethasone on IL-1R mRNA. Perhaps dexamethasone directly up-regulates the transcription of IL-1R. This possibility is supported by a report that actinomycin D completely abolished the ability of dexamethasone to increase levels of IL-1RI and IL-1RII mRNA in vitro (21) . Alternatively, perhaps dexamethasone prolongs the half-lives of IL-1RI and IL-1RII mRNA, as has been reported for human PMNs (21) .
It is interesting to note that IL-1RI mRNA, but not IL-1RII mRNA, was constitutively detected in untreated bovine PBMCs and PMNs. This differs from human PMNs, where IL-1RI mRNA typically cannot be detected unless the cells are first stimulated in vitro (9, 21) . This observation suggests that bovine PMNs maintain a higher steady-state level of IL-1RI mRNA than IL-1RII mRNA, a characteristic that would distinguish them from human neutrophils. Perhaps this can be added to the list of other characteristics, such as the absence of formyl-Met-Leu-Phe receptors (6) and the lack of detectable lysozyme (13) , that distinguish bovine from human PMNs. FIG. 3 . Northern analysis of IL-1RII mRNA in bovine PBMCs and PMNs incubated with various stimuli. (A) PBMCs were incubated at 39°C for 6 h with rBoIFN-␥ (IFN) (100 ng/ml), dexamethasone (Dex) (10 Ϫ7 M), rBoIL-1␤ (IL-1) (10 ng/ml), rBoIL-4 (IL-4) (100 ng/ml), or rBoGM-CSF (GM) (100 ng/ml), and total RNA (20 g) was examined by Northern analysis. The blots were probed with 32 P-labeled bovine IL-1RII (ϳ1.8-kb) cDNA and exposed for 7 to 14 days. (B) PMNs were incubated at 39°C for 6 h with rBoIL-1␤ (10 ng/ml), dexamethasone (10 Ϫ7 M), rBoIFN-␥ (100 ng/ml), rBoGM-CSF (100 ng/ml), or rBoIL-4 (100 ng/ml), and total RNA (10 g) was examined by Northern analysis. The blots were probed with 32 P-labeled bovine IL-1RII (ϳ1.8-kb) cDNA and exposed for 7 days. The lower part of each panel illustrates ethidium bromide staining of the 18S and 28S rRNA bands to confirm equal loading of lanes. Control lanes (C) are from cells incubated in medium alone (RPMI-1640 with 5% FBS). This figure illustrates one representative experiment that was done three times (A) or twice (B) with similar results. Table 1 provides a summary of the observations made in this study. Chief among these are that IL-1RI mRNA levels were up-regulated by rBoIL-1␤, rBoGM-CSF, rBoIL-4, rBoIFN-␥, and dexamethasone in PBMCs and down-regulated by rBoIL-1␤ and rBoIFN-␥ in PMNs. rBoIL-1␤, rBoGM-CSF, rBoIL-4, and dexamethasone increased bovine IL-1RII mRNA levels, whereas rBoIFN-␥ down-regulated IL-1RII mRNA levels. The mechanisms responsible for the differential effects of rBoIL-1␤ and IFN-␥ on IL-1RI expression in PBMCs and PMNs need to be elucidated. These data suggest that regulation of IL-1RI and IL-1RII mRNA levels in bovine and human leukocytes are generally similar but exhibit some distinct differences as well. a 1 , increased expression 2-to 10-fold; 11, increased expression 20-to 30-fold; 111, increased expression 50-to 70-fold; 2, decreased expression 30-to 50%; Ϫ, no effect.
